Current role of surgery for tuberous sclerosis complex-associated epilepsy.
Nicola SpecchioGiusy Carfi PaviaLuca de PalmaAlessandro De BenedictisChiara PepiMarta ContiCarlo Efisio MarrasFederico VigevanoPaolo CuratoloPublished in: Pediatric investigation (2022)
Tuberous sclerosis complex (TSC) is a rare multisystem, autosomal dominant neurocutaneous syndrome in which epilepsy is the most common of several neurological and psychiatric manifestations. Around two thirds of patients develop drug-resistant epilepsy for whom surgical resection of epileptogenic foci is indicated when seizures remain inadequately controlled following trial of two antiseizure medications. The challenge with presurgical and surgical approaches with patients with TSC is overcoming the complexity from the number of tubers and the multiplex epileptogenic network forming the epileptogenic zone. Data suggest that seizure freedom is achieved by 55%-60% of patients, but predictive factors for success have remained elusive, which makes for unconfident selection of surgical candidates. This article presents three different cases as illustrations of the potential challenges faced when assessing the suitability of TSC patients for epilepsy surgery.
Keyphrases
- end stage renal disease
- drug resistant
- ejection fraction
- newly diagnosed
- chronic kidney disease
- minimally invasive
- peritoneal dialysis
- multidrug resistant
- prognostic factors
- mental health
- randomized controlled trial
- coronary artery bypass
- deep learning
- patient reported
- percutaneous coronary intervention
- subarachnoid hemorrhage
- phase ii
- blood brain barrier
- phase iii